Menu
GeneBe

chr11-36098353-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_174902.4(LDLRAD3):​c.346G>A​(p.Ala116Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000039 in 1,614,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000036 ( 0 hom. )

Consequence

LDLRAD3
NM_174902.4 missense

Scores

6
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.65
Variant links:
Genes affected
LDLRAD3 (HGNC:27046): (low density lipoprotein receptor class A domain containing 3) Predicted to enable amyloid-beta binding activity. Predicted to act upstream of or within receptor-mediated endocytosis and regulation of protein processing. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.02145201).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LDLRAD3NM_174902.4 linkuse as main transcriptc.346G>A p.Ala116Thr missense_variant 4/6 ENST00000315571.6
LDLRAD3NM_001304263.2 linkuse as main transcriptc.199G>A p.Ala67Thr missense_variant 3/5
LDLRAD3NM_001304264.2 linkuse as main transcriptc.-134G>A 5_prime_UTR_variant 3/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LDLRAD3ENST00000315571.6 linkuse as main transcriptc.346G>A p.Ala116Thr missense_variant 4/61 NM_174902.4 P1Q86YD5-1
LDLRAD3ENST00000528989.5 linkuse as main transcriptc.199G>A p.Ala67Thr missense_variant 3/51 Q86YD5-2
LDLRAD3ENST00000524419.5 linkuse as main transcriptc.199G>A p.Ala67Thr missense_variant 3/65
LDLRAD3ENST00000532490.1 linkuse as main transcriptn.300G>A non_coding_transcript_exon_variant 4/54

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152198
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000152
AC:
38
AN:
250416
Hom.:
0
AF XY:
0.000155
AC XY:
21
AN XY:
135388
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00185
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000266
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000356
AC:
52
AN:
1461804
Hom.:
0
Cov.:
31
AF XY:
0.0000358
AC XY:
26
AN XY:
727208
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000982
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000108
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000722
AC:
11
AN:
152316
Hom.:
0
Cov.:
33
AF XY:
0.0000805
AC XY:
6
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00154
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000378
ExAC
AF:
0.000148
AC:
18
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 21, 2023The c.346G>A (p.A116T) alteration is located in exon 4 (coding exon 4) of the LDLRAD3 gene. This alteration results from a G to A substitution at nucleotide position 346, causing the alanine (A) at amino acid position 116 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.050
CADD
Uncertain
24
DANN
Uncertain
0.99
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.029
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.64
T;T;T
M_CAP
Benign
0.041
D
MetaRNN
Benign
0.021
T;T;T
MetaSVM
Uncertain
0.10
D
MutationTaster
Benign
0.85
D;D;D
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.92
N;N;N
REVEL
Uncertain
0.31
Sift
Benign
0.16
T;T;T
Sift4G
Benign
0.66
T;T;T
Polyphen
0.26
.;.;B
Vest4
0.32
MutPred
0.52
.;.;Gain of glycosylation at A116 (P = 0.0286);
MVP
0.80
MPC
0.18
ClinPred
0.044
T
GERP RS
5.0
Varity_R
0.056
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs563065338; hg19: chr11-36119903; COSMIC: COSV59683850; API